805-383-7509

Your Business Tagline

RemSciBiothera, Inc.

(Rom 1:16)


A Biologics Formulation Consulting Firm

Contact 

Our Mission

"To help clients develop successful pipeline formulation and characterization strategies for biologics."

Hi, I am Dr. Richard Remmele, Founder and CEO of RemSciBiothera, Inc. I would be happy to help you in meeting your Biologics formulation development needs by working with your staff and helping them achieve their goals.

Brief Biographical Sketch

Richard Remmele, Jr. received a Ph.D. in biophysical chemistry from Arizona State University. He has worked 23 years in the biotechnology industry in Formulation and Analytical scientific leadership positions. His formulation experience stretches across vaccines, oncolytic viruses, and biotherapeutics. He has led teams that developed stable formulated products through IND and BLA stages to market.

Biologic Molecules

  • Antibodies
  • Fusion Proteins
  • Peptibodies
  • Ligands
  • Cytokines​
  • Bispecifics & Multispecifics
  • Vaccines
  • Oncolytic Viruses
  • Other protein based molecular types

Qualifications 

Knowlegeable of Biologic Formulation Development

Experienced:

  • Worked with top companies (Immunex, Amgen, MedImmune)
  •  Resolved development challenges on pipeline molecules
  • Developed innovative formulations for a variety of biologics
  • Applied analytical methods to solve development problems and challenges

Accomplished:

  • 39 publications  in peer reviewed scientific journals
  • Author of 6 biotechnology book chapters
  • Inventor on several patents (formulated products, refolding of misfolded protein, etc.)
  • Successfully led the formulation development  of Enbrel and N-Plate marketed drug products

Please fill out Contact form to begin

1 (805) 383-7509